SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001140361-23-030497
Filing Date
2023-06-20
Accepted
2023-06-20 16:30:59
Documents
1
Group Members
DAVID C. OTTO. ANDREAS HALVORSENROSE S. SHABETVIKING GLOBAL OPPORTUNITIES DRAWDOWN (AGGREGATOR) LPVIKING GLOBAL OPPORTUNITIES DRAWDOWN GP LLCVIKING GLOBAL OPPORTUNITIES DRAWDOWN PORTFOLIO GP LLCVIKING GLOBAL OPPORTUNITIES GP LLCVIKING GLOBAL OPPORTUNITIES

Document Format Files

Seq Description Document Type Size
1 SC 13G brhc20054487_sc13g.htm SC 13G 395058
  Complete submission text file 0001140361-23-030497.txt   397121
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address GOOIMEER 2-35 NARRDEN P7 1411 DC
Business Address GOOIMEER 2-35 NARRDEN P7 1411 DC 35 206 2971
NewAmsterdam Pharma Co N.V. (Subject) CIK: 0001936258 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-93833 | Film No.: 231025628
SIC: 2834 Pharmaceutical Preparations